Vascular risk factors as predictors of epilepsy in older age: The Framingham Heart Study

Maria Stefanidou1,2, Jayandra J Himali1,2,3,4,5, Orrin Devinsky6

  • 1Framingham Heart Study, Framingham, Massachusetts, USA.

Epilepsia
|November 17, 2021
PubMed

Insights

High blood pressure significantly increases the risk of developing late-onset epilepsy. Managing hypertension may help prevent epilepsy in older adults, reducing overall risk by 2 to 2.5 times.

Area of Science:

  • Neurology
  • Cardiology
  • Epidemiology

Background:

  • Stroke is a leading cause of epilepsy in older adults.
  • Subclinical cerebrovascular disease is implicated in late-onset epilepsy of unknown origin.
  • Modifiable vascular risk factors are potential contributors to epilepsy development.

Purpose of the Study:

  • To investigate the role of modifiable vascular risk factors in predicting epilepsy in individuals aged 45 and older.
  • To analyze the association between hypertension and the risk of developing late-onset epilepsy.
  • To examine the Framingham Stroke Risk Profile score's predictive value for epilepsy.

Main Methods:

  • Longitudinal study of 2986 participants (mean age 58) from the Framingham Heart Study Offspring Cohort.
  • Vascular risk factors assessed included hypertension, diabetes, smoking, and hyperlipidemia.
  • Cox proportional hazards regression models were used to analyze epilepsy incidence over a mean follow-up of 19 years.

Main Results:

  • Fifty-five incident epilepsy cases were identified.
  • Hypertension was associated with a 1.93-fold increased risk of epilepsy (HR: 1.93, 95% CI: 1.10-3.37).
  • This association remained significant after adjusting for stroke, with an even stronger link (HR: 2.44, 95% CI: 1.36-4.35) when excluding treated hypertensive patients.

Conclusions:

  • Hypertension is a significant, modifiable risk factor for late-onset epilepsy.
  • The findings suggest a 2- to 2.5-fold increased risk of epilepsy associated with hypertension.
  • Managing hypertension may be a key strategy in preventing epilepsy in older populations.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...